Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study

Andrew X. Zhu, Dushyant V. Sahani, Dan G. Duda, Emmanuelle Di Tomaso, Marek Ancukiewicz, Onofrio A. Catalano, Vivek Sindhwani, Lawrence S. Blaszkowsky, Sam S. Yoon, Johanna Lahdenranta, Pankaj Bhargava, Jeffrey Meyerhardt, Jeffrey W. Clark, Eunice L. Kwak, Aram F. Hezel, Rebecca Miksad, Thomas A. Abrams, Peter C. Enzinger, Charles S. Fuchs, David P. RyanRakesh K. Jain

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences